Results 41 to 50 of about 457,403 (331)
BackgroundAs the therapeutic landscape for inflammatory bowel disease (IBD) continues to expand, a need exists to understand how patients perceive and value different attributes associated with their disease as well as with current and emerging ...
Elise Schoefs+17 more
doaj +1 more source
Two for One: Coexisting Ulcerative Colitis and Crohn’s Disease
Three cases of coexisting ulcerative colitis and Crohn’s disease are presented. In the first case, the patient had a long-standing history of ulcerative proctitis before developing Crohn’s colitis.
Grant I Chen+2 more
doaj +1 more source
DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis [PDF]
Inflammatory bowel diseases (IBD) are emerging globally, indicating that environmental factors may be important in their pathogenesis. Colonic mucosal epigenetic changes, such as DNA methylation, can occur in response to the environment and have been ...
Bronsky, Jiri+10 more
core +2 more sources
Ulcerative colitis: nutritional habits as the disease risk factor
Background — Ulcerative colitis results from a complex interaction between genetic, internal (intestinal microflora) and external (environment) factors.
Galiya R. Bikbavova+4 more
doaj +1 more source
Probiotics for maintenance of remission in ulcerative colitis.
BACKGROUND Ulcerative colitis is an inflammatory condition affecting the colon, with an annual incidence of approximately 10 to 20 per 100,000 people. The majority of people with ulcerative colitis can be put into remission, leaving a group who do not ...
Zipporah Iheozor-Ejiofor+5 more
semanticscholar +1 more source
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis [PDF]
open16noIntestinal fibrosis is a complication of inflammatory bowel disease [IBD]. Although fibrostenosis is a rare event in ulcerative colitis [UC], there is evidence that a fibrotic rearrangement of the colon occurs in the later stages.
Bassotti, Gabrio+15 more
core +2 more sources
Background and Aims: Inflammatory mediator S100A9 is dramatically elevated in ulcerative colitis and correlates with disease severity. S100A9 is a potential molecule to target for the treatment of colitis, but to date, there is no effective targeting ...
Zhengshuo Li+8 more
doaj +1 more source
Ulcerative Colitis and Cytomegalovirus Infection: From A to Z.
Despite multiple studies, the role of CMV infection in exacerbating the severity of inflammation in ulcerative colitis (UC) and its response to treatment remains debatable. Additionally, the optimal diagnostic tests for CMV infection in the setting of UC
F. Mourad+3 more
semanticscholar +1 more source
CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis. [PDF]
As scientific techniques for the detection of cytomegalovirus (CMV) improve, we are able to detect small amounts of CMV in the mucosal wall. As clinicians, we are unsure how to interpret the results of this novel test.
Goodman, AL+4 more
core +1 more source
Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies
Dynamic interactions between the gastrointestinal epithelium and the mucosal immune system normally contribute to ensuring intestinal homeostasis and optimal immunosurveillance, but destabilisation of these interactions in genetically predisposed ...
Amandip Kaur, P. Goggolidou
semanticscholar +1 more source